A detailed history of Thompson Siegel & Walmsley LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 76,284 shares of LNTH stock, worth $6.17 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
76,284
Holding current value
$6.17 Million
% of portfolio
0.12%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$77.7 - $123.62 $5.93 Million - $9.43 Million
76,284 New
76,284 $8.37 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.56B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.